CBU
VCYT icon

CIBC Bancorp USA’s Veracyte VCYT Stock Holding History

CIBC Bancorp USA’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$287K Buy
+8,356
New +$240K ﹤0.01% 1109

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Bancorp USA's VCYT Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Veracyte (VCYT) in Q3 2025: 8,356 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #1109 among its holdings.

298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • CIBC Bancorp USA held 8,356 shares of Veracyte worth $287K as of Q3 2025.
  • Veracyte was a new CIBC Bancorp USA position in Q3 2025.
  • Veracyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1109 holding.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.